• Home
  • Stock
  • Beta Drugs Fundamental Analysis
  • Beta Drugs Fundamental Analysis

Beta Drugs fundamental analysis

BETA

HealthcareSmall

1640

31.40 (-1.88%)
Last updated on 6 Dec, 2025 | 14:05 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Beta Drugs Fundamentals

P/E Ratio

38.84

P/B Ratio

8.36

Div. Yield

0

Sector P/E

36.18

Sector P/B

0.98

Sec. Div. Yield

0.56

  • Beta Drugs Fundamentals is currently trading with a P/E Ratio of 38.84, compared to the sector average of 36.18. Its P/B Ratio stands at 8.36, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.

Beta Drugs Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Beta Drugs reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.